Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer.
作者:
主题词
佐剂, 免疫(Adjuvants, Immunologic);投药, 膀胱内(Administration, Intravesical);老年人(Aged);老年人, 80以上(Aged, 80 and over);卡介苗(BCG Vaccine);综合疗法(Combined Modality Therapy);女(雌)性(Female);坚持准则(Guideline Adherence);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);肿瘤分期(Neoplasm Staging);诊疗准则(主题)(Practice Guidelines as Topic);比例危险度模型(Proportional Hazards Models);登记(Registries);再手术(Reoperation);性别因素(Sex Factors);存活率(Survival Rate);瑞典(Sweden);治疗结果(Treatment Outcome);膀胱肿瘤(Urinary Bladder Neoplasms)
DOI
10.1080/21681805.2018.1462254
PMID
29676191
发布时间
2019-02-01
- 浏览6

Scandinavian journal of urology
2018年52卷3期
186-193页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文